From prejudice to evidence: The case of rhizoma coptidis in singapore

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Ho, Chin Ee ^a,b   Goh, You Li ^a,b   Zhang, Chang ^a  

^a BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BERBERINE;

COPTIS; DRUG SAFETY; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HERBAL MEDICINE; IN VITRO STUDY; IN VIVO STUDY; KERNICTERUS; NEWBORN JAUNDICE; NONHUMAN; PREJUDICE; REVIEW; SINGAPORE;

EID: 84920520149     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/871720     Document Type: Review

References (68)

1. Y.-C. Linn, J. Lu, L.-C. Lim et al., "Berberine-induced haemolysis revisited: safety of Rhizoma coptidis and Cortex phellodendri in chronic haematological diseases," Phytotherapy Research, vol. 26, no. 5, pp. 682-686, 2012.
2. J.-T. Xu, L.-Q. Wang, and B. Xu, "Research development of Coptis chinensis," Zhongguo Yi Xue Ke Xue Yuan Xue Bao, vol. 26, no. 6, pp. 704-707, 2004.
3. F.Chen and X. S. Gao, "Huanglian-containing prescriptions and dispesations in ancient Chinese literatures," Chinese Traditional Patent Medicine, no. 19, pp. 40-41, 1997.
4. K. Tanaka, K. Nara, T. Nishimura et al., "Fever of unknown origin successfully treated by oren-gedoku-to (huanglian-jiedu- tang)," International Journal of General Medicine, vol. 6, pp. 829-832, 2013.
5. S.-C. Lin, C.-C. Lin, F.-J. Lu, Y.-H. Lin, and C.-H. Chen, "Protective and therapeutic effects of huanglian-jie-du-tang on hepatotoxin-induced liver injuries," The American Journal of Chinese Medicine, vol. 24, no. 3-4, pp. 219-229, 1996.
6. Y. Ohta, T. Kobayashi, K. Nishida, E. Sasaki, and I. Ishiguro, "Preventive effect of Oren-gedoku-to (Huanglian-Jie-Du-Tang) extract on the development of stress-induced acute gastric mucosal lesions in rats," Journal of Ethnopharmacology, vol. 67, no. 3, pp. 377-384, 1999.
7. Y.-H. Hu, J. Li, N.-J. Wu, and S. Wu, "Clinical observation on effect of modified huanglian wendan decoction in treating diabetic asymptomatic myocardial ischemia," Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 25, no. 9, pp. 790-793, 2005.
8. S. Yang and X. Wang, "A research on the erupted fetal diseases caused by traditional Chinese drugs-discussion fromthe issue that Chinese Goldthread Rhizome is prohibited in Singapore," Journal of Traditional Chinese Medicine, vol. 28, no. 3, pp. 235- 240, 2008.
9. J. Tang, Y. Feng, S. Tsao, N. Wang, R. Curtain, and Y. Wang, "Berberine and Coptidis Rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations," Journal of Ethnopharmacology, vol. 126, no. 1, pp. 5-17, 2009.
10. W. Kong, J. Wang, X. Xiao, S. Chen, and M. Yang, "Evaluation of antibacterial effect and mode of Coptidis rhizoma by microcalorimetry coupled with chemometric techniques," Analyst, vol. 137, no. 1, pp. 216-222, 2012.
11. X. Wang, X. Yao, Z. Zhu et al., "Effect of berberine on Staphylococcus epidermidis biofilm formation," International Journal of Antimicrobial Agents, vol. 34, no. 1, pp. 60-66, 2009.
12. G. H. Rabbani, T. Butler, J. Knight, S. C. Sanyal, and K. Alam, "Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae," The Journal of Infectious Diseases, vol. 155, no. 5, pp. 979-984, 1987.
13. S. Letašiova, S. Jantova, M. Horvathova, and B. Lakatoš, "Toxicity and apoptosis induced by berberine-a potential anticancer drug," Biologia, vol. 60, no. 17, pp. 97-100, 2005.
14. W. Tan, Y. Li,M. Chen, and Y.Wang, "Berberine hydrochloride: anticancer activity and nanoparticulate delivery system," International Journal of Nanomedicine, vol. 6, pp. 1773-1777, 2011.
15. X.-K. Li, M. Motwani, W. Tong, W. Bornmann, and G. K. Schwartz, "Huanglian, a Chinese herbal extract, inhibits cell growth by suppressing the expression of cyclin B1 and inhibiting CDC2 kinase activity in human cancer cells," Molecular Pharmacology, vol. 58, no. 6, pp. 1287-1293, 2000.
16. J. X. Kang, J. Liu, J. Wang, C. He, and F. P. Li, "The extract of huanglian, a medicinal herb, induces cell growth arrest and apoptosis by upregulation of interferon and TNF-α in human breast cancer cells," Carcinogenesis, vol. 26,no. 11,pp. 1934-1939, 2005.
17. H. L.Wu, C. Y. Hsu, W. H. Liu, and B. Y.M. Yung, "Berberineinduced apoptosis of human leukemia HL-60 cells is associated with down-regulation of nucleophosmin/B23 and telomerase activity," International Journal of Cancer, vol. 81, no. 6, pp. 923- 929, 1999.
18. C.-C. Lin, S.-T. Kao, G.-W. Chen, H.-C. Ho, and J.-G. Chung, "Apoptosis of human leukemia HL-60 cells and murine leukemia WEHI-3 cells induced by berberine through the activation of caspase-3," Anticancer Research, vol. 26, no. 1A, pp. 227-242, 2006.
19. H.-L. Lin, T.-Y. Liu, C.-W. Wu, and C.-W. Chi, "Berberine modulates expression of mdr1 gene product and the responses of digestive track cancer cells to Paclitaxel," British Journal of Cancer, vol. 81, no. 3, pp. 416-422, 1999.
20. J. P. Lin, H.-F. Lu, and T.-C. Hsia, "Berberine induced in vitro G2/M arrest of cell cycle and apoptosis in human gastric cancer Snu-5 cells," Anticancer Research, vol. 24, no. 5D, p. 3551, 2004.
21. L. Pinto-Garcia, T. Efferth, A. Torres, J. D. Hoheisel, and M. Youns, "Berberine inhibits cell growth and mediates caspaseindependent cell death in human pancreatic cancer cells," Planta Medica, vol. 76, no. 11, pp. 1155-1161, 2010.
22. C.-H. Li,D.-F. Wu,H.Ding, Y. Zhao, K.-Y. Zhou, and D.-F. Xu, "Berberine hydrochloride impact on physiological processes and modulation of twist levels in nasopharyngeal carcinoma CNE-1 cells," Asian Pacific Journal of Cancer Prevention, vol. 15, no. 4, pp. 1851-1857, 2014.
23. Y. Feng, N. Wang, X. Ye, H. Li, F. Cheung, and T. Nagamatsu, "Hepatoprotective effect and its possible mechanism of Coptidis rhizoma aqueous extract on carbon tetrachloride-induced chronic liver hepatotoxicity in rats," Journal of Ethnopharmacology, vol. 138, no. 3, pp. 683-690, 2011.
24. R. Domitrovic, O. Cvijanovic, E. Pernjak-Pugel, M. Škoda, L. Mikelic, and Z. Crncevic-Orlic, "Berberine exerts nephroprotective effect against cisplatin-induced kidney damage through inhibition of oxidative/nitrosative stress, inflammation, autophagy and apoptosis," Food and Chemical Toxicology, vol. 62, pp. 397-406, 2013.
25. Y.-S. Chai, Z.-Y. Yuan, F. Lei et al., "Inhibition of retinoblastoma mRNA degradation through poly (A) involved in the neuroprotective effect of berberine against cerebral ischemia," PLoSONE, vol. 9, no. 3, Article IDe90850, 2014.
26. X.-H. Zeng, X.-J. Zeng, and Y.-Y. Li, "Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy," The American Journal of Cardiology, vol. 92, no. 2, pp. 173-176, 2003.
27. K. G. Perez-Rubio, M. Gonzalez-Ortiz, E. Martinez-Abundis, J. A. Robles-Cervantes, and M. C. Espinel-Bermudez, "Effect of berberine administration on metabolic syndrome, insulin sensitivity, and insulin secretion," Metabolic Syndrome and Related Disorders, vol. 11, no. 5, pp. 366-369, 2013.
28. W.-J. Kong, J. Wei, Z.-Y. Zuo et al., "Combination of simvastatin with berberine improves the lipid-lowering efficacy," Metabolism: Clinical and Experimental, vol. 57, no. 8, pp. 1029- 1037, 2008.
29. J. Y. Zhou, S. W. Zhou, K. B. Zhang et al., "Chronic effects of berberine on blood, liver glucolipid metabolism and liver PPARs expression in diabetic hyperlipidemic rats," Biological and Pharmaceutical Bulletin, vol. 31, no. 6, pp. 1169-1176, 2008.
30. J. Yin, H. Xing, and J. Ye, "Efficacy of berberine in patients with type 2 diabetes mellitus," Metabolism, vol. 57, no. 5, pp. 712-717, 2008.
31. S.-K. Yee, S.-S. Chu, Y.-M. Xu, and P.-L. Choo, "Regulatory control of Chinese proprietary medicines in Singapore," Health Policy, vol. 71, no. 2, pp. 133-149, 2005.
32. M. K. Lim, P. Sadarangani, H. L. Chan, and J. Y. Heng, "Complementary and alternative medicine use in multiracial Singapore," Complementary Therapies in Medicine, vol. 13, no. 1, pp. 16-24, 2005.
33. R. Joseph, L. Y. Ho, J.M.Gomez,V. S.Rajdurai, S. Sivasankaran, and Y. Y. Yip, "Mass newborn screening for glucose-6- phosphate dehydrogenase deficiency in Singapore," Southeast Asian Journal of Tropical Medicine and Public Health, vol. 30, no. 2, pp. 70-71, 1999.
34. "Kernikterus not associated with haemolytic disease," Archives of Disease in Childhood, vol. 32, no. 162, pp. 85-90, 1957.
35. H. B. Wong, "Singapore kernicterus," Journal of the Singapore Paediatric Society, vol. 21, no. 3-4, pp. 218-231, 1979.
36. A. Leong, "Is there a need for neonatal screening of glucose- 6-phosphate dehydrogenase deficiency in Canada?" McGill Journal of Medicine, vol. 10, no. 1, pp. 31-34, 2007.
37. T. Valaes, "Severe neonatal jaundice associated with glucose-6- phosphate dehydrogenase deficiency: pathogenesis and global epidemiology," Acta Paediatrica, International Journal of Paediatrics, Supplement, vol. 83, no. 394, pp. 58-76, 1994.
38. E. Beutler, "G6PD deficiency," Blood, vol. 84, no. 11, pp. 3613- 3636, 1994.
39. S. Zangen, D. Kidron, T. Gelbart, N. Roy-Chowdhury, X. Wang, and M. Kaplan, "Fatal kernicterus in a girl deficient in glucose-6-phosphate dehydrogenase: a paradigm of synergistic heterozygosity,"The Journal of Pediatrics, vol. 154, no. 4,pp. 616-619, 2009.
40. T. F. Fok, S. P. Lau, and C. W. Hui, "Neonatal jaundice: its prevalance in Chinese babies and associating factors," Australian Paediatric Journal, vol. 22, no. 3, pp. 215-219, 1986.
41. H.Wajcman and F. Galacteros, "Glucose 6-phosphate dehydrogenase deficiency: a protection against malaria and a risk for hemolytic accidents," Comptes Rendus-Biologies, vol. 327, no. 8, pp. 711-720, 2004.
42. W. H. Zinkham and F. A. Oski, "Henna: a potential cause of oxidative hemolysis and neonatal hyperbilirubinemia," Pediatrics, vol. 97, no. 5, pp. 707-709, 1996.
43. E. Beutler, G. Gaetani, V. Der Kaloustian, L. Luzzatto, and O. Sodeinde, "Glucose-6-phosphate dehydrogenase deficiency," Bulletin of theWorld Health Organization, vol. 67, no. 6, pp. 601- 611, 1989.
44. M. Schuurman,D.VanWaardenburg, J. D. Costa, H. Niemarkt, and P. Leroy, "Severe hemolysis and methemoglobinemia following fava beans ingestion in glucose-6-phosphatase dehydrogenase deficiency-case report and literature review," European Journal of Pediatrics, vol. 168, no. 7, pp. 779-782, 2009.
45. A. M. Tunioli, "Glucose-6-phosphate dehydrogenase activity in the erythrocytes of children with favism, during and at various intervals after the hemolytic attack," Bollettino della Societa Italiana di Biologia Sperimentale, vol. 40, no. 24, pp. 1734-1737, 1964.
46. T. Boussemart, A. Nasimi, F. Millot, M. Berthier, and D. Oriot, "G6PD deficiency revealed by eating of beans and the ingestion of sulfamethoxazole," La PresseMédicale, vol. 24, no. 20, p. 960, 1995.
47. B. E. Rosenbloom, S. Weingarten, F. P. Rosenfelt, and I. M. Weinstein, "Severe hemolytic anemia due to glucose-6- phosphate dehydrogenase deficiency and Epstein-Barr virus infection," Mount Sinai Journal of Medicine, vol. 55, no. 5, pp. 404-405, 1988.
48. F. A. Quereshy, E. S. Gold, and M. P. Powers, "Hemolytic anemia in a glucose-6-phosphate dehydrogenase-deficient patient triggered by a maxillofacial infection," Journal of Oral and Maxillofacial Surgery, vol. 58, no. 7, pp. 805-807, 2000.
49. N. K. Ho, "Traditional Chinese medicine and treatment of neonatal jaundice," Singapore Medical Journal, vol. 37, no. 6, pp. 645-651, 1996.
50. H. B.Wong, "Singapore kernicterus," SingaporeMedical Journal, vol. 21, no. 3, pp. 556-567, 1980.
51. C. H. Ko, K. Li, P. C. Ng et al., "Pro-oxidative effects of Chinese herbal medicine on G6PD-deficient erythrocytes in vitro," Toxicology in Vitro, vol. 22, no. 5, pp. 1222-1227, 2008.
52. E. Chan, "Displacement of bilirubin from albumin by berberine," Biology of the Neonate, vol. 63, no. 4, pp. 201-208, 1993.
53. C. Y. Yeung, F. T. Lee, and H. N. Wong, "Effect of a popular Chinese herb on neonatal bilirubin protein binding," Biology of the Neonate, vol. 58, no. 2, pp. 98-103, 1990.
54. H. Li and X. Cai, "The new applications and the side effects of Rhizoma Coptidis in clinic," Medical Journal of the Chinese Peoples Armed Polices Forces, vol. 19, pp. 661-663, 2008.
55. B.-L.Ma, Y.-M.Ma, R. Shi et al., "Identification of the toxic constituents in Rhizoma Coptidis," Journal of Ethnopharmacology, vol. 128, no. 2, pp. 357-364, 2010.
56. J. Yi, X. Ye,D.Wang et al., "Safety evaluation of main alkaloids fromRhizoma Coptidis," Journal of Ethnopharmacology, vol. 145, no. 1, pp. 303-310, 2013.
57. Y.-H. Lee, D. Kim, M. J. Lee et al., "Subchronic toxicity study of Coptidis Rhizoma in rats," Journal of Ethnopharmacology, vol. 152, no. 3, pp. 457-463, 2014.
58. M. M. Kheir, Y.Wang, L. Hua et al., "Acute toxicity of berberine and its correlation with the blood concentration in mice," Food and Chemical Toxicology, vol. 48, no. 4, pp. 1105-1110, 2010.
59. N. Lin, X. Gao, J. Li, and J. Zhu, "Influence of huanglian and berberine on the erythrocytic osmotic fragilitas of experimental glucose-6-phosphate dehydrogenase deficiency in rats," Zhongguo Zhong Yao Za Zhi, vol. 23, no. 9, pp. 562-564, 1998.
60. Y.Xu, C.-F.Liu,B.Yang, Y.-W.Wang, L. Qiao, andN. Lin, "Study on effect of coptidis rhizoma on red blood cells of normal mice and its antioxidant property," Zhongguo Zhong Yao Za Zhi, vol. 37, no. 21, pp. 3288-3292, 2012.
61. R. Wang and N. Lin, "Research of coptis effect on incidence of neonatal jaundice based on Cox model," Zhongguo Zhong Yao Za Zhi, vol. 35, no. 10, pp. 1335-1338, 2010.
62. T. F. Fok, S. P. Lau, and C.W. Hui, "Chinese herbs in pregnancy and neonatal jaundice," Hong Kong Journal of Pediatrics, vol. 2, pp. 138-144, 1985.
63. Y.-H. Weng, Y.-H. Chou, and R.-I. Lien, "Hyperbilirubinemia in healthy neonates with glucose-6-phosphate dehydrogenase deficiency," Early Human Development, vol. 71, no. 2, pp. 129- 136, 2003.
64. Y.-H.Weng, Y.-W. Chiu, and S.-W. Cheng, "Breastmilk jaundice and maternal diet with Chinese herbal medicines," Evidencebased Complementary and Alternative Medicine, vol. 2012, Article ID 150120, 6 pages, 2012.
65. C.-H. Chuang, J.-N. Lai, J.-D. Wang, P.-J. Chang, and P.-C. Chen, "Use of coptidis Rhizoma and foetal growth: a followupstudy of 9895 pregnancies," Pharmacoepidemiology andDrug Safety, vol. 15, no. 3, pp. 185-192, 2006.
66. X.-L. Lin, N. Lin, C.-F. Liu et al., "Investigation of Coptis chinensis on jaundice of glucose-6-phosphate dehydrogenase (G6PD) deficient neonates from Guigang, Guangxi province," Zhongguo Zhongyao Zazhi, vol. 32, no. 23, pp. 2543-2546, 2007.
67. X.S.Gao,F.X.Chen, S. Y. Yang et al., "Acomprehensive studyon kernicterus induced by Rhizoma coptidis and its prevention," China Journal of Materia Medica, vol. 27, no. 1, pp. 70-74, 2002.
68. Health Sciences Authority, HSA Allows Chinese Proprietary Medicines Containing Berberine for Sale in Singapore from 1 January 2013, Health Sciences Authority, Singapore, 2012.